A lifeline for rare disease patientsFor more than 25 years Alexion has been blazing a trail in rare diseases, bringing a series of Share XA lifeline for rare disease patientshttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/alexion-sean-richardson-charles-de-wet/
Realising the potential of wearable techSpire Health, a US-based continuous respiration sensing and high-adherence ambulatory monitoring healthcare company, is poised to revolutionise the Share XRealising the potential of wearable techhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/spire-health-clinical-trial-wearables/
Precision medicine: AZ’s Ruth March on its next stepsAstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the Share XPrecision medicine: AZ’s Ruth March on its next stepshttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/astrazeneca-ruth-march-precision-medicine/
Innovating in clinical trial recruitmentClinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients Share XInnovating in clinical trial recruitmenthttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/havas-lynx-faze-clinical-trials/
Company profile: IDEA PharmaWe are in the most competitive period ever for the pharmaceutical industry, characterised by incremental innovation and looming Share XCompany profile: IDEA Pharmahttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/idea-pharma-strategy/
Reimagining the future of healthcareJohnson & Johnson’s global head of external innovation, William ‘Bill’ Hait, describes innovation as often being “an overnight Share XReimagining the future of healthcarehttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/johnson-innovation-william-hait/
